Renal cancerBevacizumab coupons
Bevacizumab

Bevacizumab Coupons & Savings Card – Discount Prices from $38.10

Avastin (bevacizumab) is a specialized cancer treatment utilized for managing various cancers such as cervical, colorectal, and glioblastoma. It is often administered in conjunction with other cancer medications but can be used alone depending on the cancer type. Avastin is delivered intravenously by a healthcare provider, typically every 2 to 3 weeks. While generally well-tolerated, some patients may experience side effects like high blood pressure and delayed wound healing. Avastin is indicated for treating metastatic, recurrent, or persistent cervical cancer, metastatic colorectal cancer, recurrent glioblastoma, metastatic or unresectable liver cancer, nonsquamous non-small cell lung cancer, ovarian, fallopian tube, primary peritoneal cancer, and metastatic kidney cancer. Avastin functions as a vascular endothelial growth factor (VEGF) inhibitor, a targeted therapy that obstructs the VEGF protein. This protein is crucial for cancer cell growth as it supports blood supply expansion. By inhibiting VEGF, Avastin effectively cuts off the blood supply to the cancer, thus helping to slow its growth. Always consult with healthcare professionals for personalized medical advice and treatment plans.
Our coupons are free to use. Before paying, show the pharmacist your Bevacizumab savings card to get your free discount. Use our filters below to edit the prescription box to match your needs. The Bevacizumab prices will update based on your prescription needs. Above our Bevacizumab coupons, you can change your location to see pharmacy prices and costs in other areas. We're here to help you buy Bevacizumab at the lowest price with our prescription discount card.

My prescription

Edit

0.05ML of 1.25MG/0.05ML, Bevacizumab (1 Syringe)

Select pharmacy

Pharmacy logo

CVS

$72.12

COUPON PRICE
Pharmacy logo

Walmart

$38.10

COUPON PRICE
Pharmacy logo

Rite Aid

$45.79

COUPON PRICE
Pharmacy logo

Walgreens

$49.09

COUPON PRICE

Bevacizumab savings card

Show this card to your pharmacist
Pharmacy logo

Walmart

$38.10

BIN

ID

PCN

GRP

019876

LH78A56D26

CHIPPO

LHX

Powered by

This card is not insurance

More prescriptions for renal cancer

coupons from$22.56Save 60%
coupons from$1766.10Save 73%
coupons from$35.64Save 84%
coupons from$8.07Save 66%
coupons from$42.18Save 84%
coupons from$3503.90Save 72%
coupons from$1143.98Save 73%
coupons from$42.18Save 84%

More prescriptions for renal cancer

Depo-provera Save 60%coupons from $22.56
Nexavar Save 73%coupons from $1766.10
Depo-subq Provera 104 Save 84%coupons from $35.64
Medroxyprogesterone Save 66%coupons from $8.07
Everolimus Save 84%coupons from $42.18
Inlyta Save 72%coupons from $3503.90
Afinitor Save 73%coupons from $1143.98
Zortress Save 84%coupons from $42.18

Price history for Bevacizumab (generic)

1, 0.05ML of 1.25MG/0.05ML

Average retail price for Bevacizumab

Average SaveHealth price for Bevacizumab

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

We analyzed Bevacizumab prices for (0.05ML of 1.25MG/0.05ML, 1 Syringe) over the last 12 months. The average retail price was $188.78, while the average price using the SaveHealth discount card was $61.78. That's a savings of approximately 67.27% when using our Bevacizumab coupon.

Bevacizumab dosage forms

Use our Bevacizumab 0.05ML of 1.25MG/0.05ML coupon with prices from $38.10 for 1 Syringe. You can also use our Bevacizumab 0.08ML of 2MG/0.08ML coupon with prices from $45.37 for 1 Syringe. We have a Bevacizumab 0.09ML of 2.25MG/0.09ML coupon with prices from $61.97 for 1 Syringe. You can use our Bevacizumab 0.1ML of 2.5MG/0.1ML coupon with prices from $66.74 for 1 Syringe.
DosageQuantityPrice fromPer unit
0.05ML of 1.25MG/0.05ML1 Syringe$38.10$38.10
0.08ML of 2MG/0.08ML1 Syringe$45.37$45.37
0.09ML of 2.25MG/0.09ML1 Syringe$61.97$61.97
0.1ML of 2.5MG/0.1ML1 Syringe$66.74$66.74
0.11ML of 2.75MG/0.11ML1 Syringe$81.27$81.27
0.13ML of 3.25MG/0.13ML1 Syringe$77.12$77.12
0.15ML of 3.75MG/0.15ML1 Syringe$15.71$15.71

Bevacizumab Warnings

The safety information for Avastin (bevacizumab) is crucial for understanding the potential risks and precautions associated with its use. Patients and healthcare providers should take note of the following:

  • Gut Injuries and Fistulas: Although rare, some individuals may experience serious gut injuries or fistulas, particularly those who have undergone pelvic radiation or are being treated for cervical cancer. Most gut tears occur within two months of starting Avastin, and fistulas typically develop within six months. Be vigilant for symptoms such as high fever, intense stomach pain, or severe constipation, and inform your healthcare provider immediately if they occur.

  • Surgery and Wound Healing: Avastin can impede wound healing. Inform your healthcare provider if surgery is planned, as Avastin should be discontinued at least a month before and after surgery until wounds are fully healed.

  • Serious Bleeding: There is an increased risk of severe bleeding in various parts of the body, including the lungs, stomach, and brain. Immediate medical attention is required if bleeding occurs.

  • Serious Blood Clots: Avastin may elevate the risk of blood clots, which can lead to stroke or heart attack. Individuals with a history of blood clots, high cholesterol, smoking habits, or high blood pressure should be particularly cautious. Symptoms like chest pain, breathing difficulties, or leg swelling need urgent medical evaluation.

  • High Blood Pressure: Regular monitoring of blood pressure is essential, as Avastin can cause hypertension. Treatment may be adjusted if blood pressure becomes uncontrollable.

  • Posterior Reversible Encephalopathy Syndrome (PRES): Although exceedingly rare, PRES is a potential side effect. Symptoms such as headaches, confusion, or vision problems should be reported to your provider.

  • Kidney Problems: The risk of kidney issues exists, potentially manifesting from two weeks to three years after starting treatment. Regular kidney function tests are necessary, and any changes in urination should be discussed with your provider.

  • Infusion Reactions: Serious reactions can occur during or after Avastin infusions, including chest pain or trouble breathing. Immediate medical attention is crucial if these symptoms arise.

  • Harm to an Unborn Baby: Avastin may harm an unborn child. Women of childbearing potential should use contraception during treatment and for six months after the last dose. Notify your provider if pregnancy occurs during this period.

  • Potential Fertility Issues: There is a possibility that Avastin could affect female fertility. Discuss fertility preservation options with your provider if future childbearing is a consideration.

  • Heart Problems: If you have previously received anthracycline-based chemotherapy, notify your healthcare provider due to the increased risk of heart failure. Symptoms like difficulty breathing or swelling should be reported immediately.

This information is vital for ensuring safe and informed use of Avastin. Always discuss any concerns or symptoms with your healthcare provider.

Bevacizumab Side Effects

Common side effects:

  • Nosebleeds
  • Headaches
  • High blood pressure
  • Runny nose
  • Increased protein levels in urine
  • Changes in taste
  • Dry skin
  • Difficulty stopping bleeding
  • Dry eyes or excessive tearing
  • Back pain
  • Peeling and blistering skin

    Less common but important to monitor:

  • Infusion reactions (trouble breathing, itching, swelling, or fast heartbeat)

    Serious side effects:

  • Gastrointestinal issues (tears in the gut with fever, chills, intense stomach pain, or bloating)
  • Fistulas (skin irritation, discharge, swelling, or redness around the anus, blood in the stool)
  • Serious bleeding episodes (unusual bleeding, easy bruising, chest pain, coughing, black, tarry stools)
  • Blood clots (affecting lungs, heart, or legs)
  • Dangerously high blood pressure (anxiety, blurry vision, confusion, nausea)
  • Kidney problems (nausea, vomiting, fatigue, reduced urination, cloudy urine)
Bevacizumab FAQs
What is the drug bevacizumab used for?

Bevacizumab is used to treat various types of cancer, including colorectal cancer, lung cancer, glioblastoma, kidney cancer, and ovarian cancer. It works by inhibiting the growth of blood vessels that supply nutrients to tumors, thereby slowing or stopping their growth.

The use of bevacizumab is considered controversial primarily due to concerns about its safety and efficacy in certain conditions. While it is approved for specific cancers, its off-label use, particularly in ophthalmology for age-related macular degeneration, has raised issues. There are concerns about potential side effects, such as increased risk of bleeding and gastrointestinal perforations, as well as the cost-effectiveness compared to other treatments. Additionally, there have been debates over its benefit-risk profile in certain patient populations.

Avastin (bevacizumab) is neither a traditional chemotherapy nor an immunotherapy. It is classified as a targeted therapy, specifically a monoclonal antibody that inhibits angiogenesis by targeting vascular endothelial growth factor (VEGF). This action helps to prevent the growth of new blood vessels that tumors need to grow and spread.

Avastin was not banned entirely, but its approval for the treatment of breast cancer was revoked by the U.S. Food and Drug Administration (FDA) in 2011. This decision was based on evidence that Avastin did not demonstrate a sufficient benefit in terms of delaying tumor growth in breast cancer patients to outweigh the risks, which included severe side effects such as high blood pressure, bleeding, and heart problems. However, Avastin remains approved for use in other types of cancer, such as colorectal, lung, kidney, and glioblastoma, where it has shown effectiveness.

Bevacizumab carries a black box warning for several serious risks. These include gastrointestinal perforations, which can be life-threatening; wound healing complications, as bevacizumab can impair the healing process; and severe or fatal hemorrhage, including pulmonary hemorrhage or hemoptysis. It is important for patients to be monitored closely for these potential adverse effects.